v3.25.4
Shareholders' Equity - Restricted stock unit (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Share-Based Compensation Expenses    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of year 111,359  
Number of other equity instruments outstanding in share-based payment arrangement at end of year 107,257 111,359
Restricted Share Units    
Share-Based Compensation Expenses    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of year 111,359 102,104
Granted 36,813 50,438
Settled (33,274) (18,340)
Forfeited (7,641) (22,843)
Number of other equity instruments outstanding in share-based payment arrangement at end of year 107,257 111,359
Fair value of RSUs granted | $ $ 5.9 $ 5.8
Stock-based compensation expenses | $ 5.3 4.8
Capitalised to royalty, stream and working interest | $ 0.1 0.3
Total unrecognized non-cash stock-based compensation expense | $ $ 6.0 $ 5.3
Expected to be recognized over weighted average period 1 year 3 months 18 days 1 year 8 months 12 days
Performance based RSU    
Share-Based Compensation Expenses    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of year 76,020 71,051
Granted 21,731 29,694
Settled (16,368) (2,639)
Forfeited (7,641) (22,086)
Number of other equity instruments outstanding in share-based payment arrangement at end of year 73,742 76,020
Time-based RSU    
Share-Based Compensation Expenses    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of year 35,339 31,053
Granted 15,082 20,744
Settled (16,906) (15,701)
Forfeited   (757)
Number of other equity instruments outstanding in share-based payment arrangement at end of year 33,515 35,339